New research from the US suggests that use of hormone therapy may affect women's risk for developing Alzheimer's disease: those who start it within five years of menopause may experience a lower risk, and those who start it later may experience a raised risk for the neurodegenerative disease. Peter P. Zandi of Johns Hopkins University in Baltimore and colleagues write about their findings in a paper that was published online in the journal Neurology on Wednesday...
More...
More...